Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?
about
Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health StudyThe effect of sampling more cores on the predictive accuracy of pathological grade and tumour distribution in the prostate biopsy.Correlation of concentrations of selected trace elements with Gleason grade of prostate tissuesHigh-risk prostate cancer in the United States, 1990-2007Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 studyContemporary trends in low risk prostate cancer: risk assessment and treatmentThe changing face of low-risk prostate cancer: trends in clinical presentation and primary management.Outcomes of active surveillance for men with intermediate-risk prostate cancer.Clinical significance of a large difference (≥ 2 points) between biopsy and post-prostatectomy pathological Gleason scores in patients with prostate cancerA contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomyContinued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea.A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival.'Insignificant' prostate cancer on biopsy: pathologic results from subsequent radical prostatectomy.Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerGleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?Prognostic determinants in prostate cancer.Gleason inflation 1998-2011: a registry study of 97,168 men.Is there a difference in outcome after radical prostatectomy between patients with biopsy Gleason sums 4, 5, and 6? Results from the SEARCH database.Survival analysis of patients with biochemical relapse after radical prostatectomy treated with androgen deprivation: Castration-resistance influential factors.The relationship between preoperative prostate-specific antigen and biopsy Gleason sum in men undergoing radical retropubic prostatectomy: a novel assessment of traditional predictors of outcome.Radiotherapy and survival in prostate cancer patients: a population-based study.The influence of expertise of the surgical pathologist to undergrading, upgrading, and understaging of prostate cancer in patients undergoing subsequent radical prostatectomy.Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart.Characteristics of image-detected solid renal masses: implication for optimal treatment.Prostate cancer and the Will Rogers phenomenon.A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies.Histological upgrading and upstaging in the UK population following radical prostatectomy and their implications for active surveillance
P2860
Q24650442-6C029CDB-2A51-4CA9-BBDB-850B6711DB1CQ30312087-BFA6FCD6-C361-4EDB-9398-6F24EC24ECEEQ34102367-CE6823A5-AF1D-4D7B-9AE3-1987589E1A21Q34168382-FF1C185D-6516-46CD-A508-78C9999150ADQ34179268-D62A5762-F7BF-4680-8D6E-9FDF0238E1F9Q34330041-CD29D512-F08D-4E25-B97D-FD4DF0D97EC6Q34380870-FEFBBCA6-FBD7-4772-AC75-6667D25C0D92Q34679207-788EE457-7A69-4E2A-BE3B-A35B6BA9AEF7Q34753331-FA50CDDD-872C-43B3-BFA6-E7B1DC5D3D85Q35322697-17691E27-DC14-4AD1-8D53-BCB4F9B487D5Q35775984-8BDB1E65-FEC0-4E3D-BC1F-F98D56FF21BCQ36374511-9BB0D341-6A6D-45A3-88B2-C6880A529A92Q36614192-FC6C986F-3342-40F8-8C07-E84674DDA818Q36771260-E4212AD5-6E49-4A4C-9681-E1E95CDDC553Q37107560-213652BF-C298-4DDB-88D2-68118F84A465Q37280719-3E94B3C5-96B2-420F-AB5A-4664A9DBF7A4Q37966912-0C5C808D-61B3-47E4-8961-5D50DFD2A2B7Q39199397-A2CF94A8-2160-4559-A91A-4271CFF7B3CBQ39219786-12FAED69-3804-450B-ACAC-5B387C5DD369Q40100825-20E7AB7E-E79C-4714-89D5-226921E937B2Q41004138-23B76003-E365-495A-9ED6-7B705B8E9BD7Q42552729-AAC1153A-8F08-40FD-8448-BD5FC17020FAQ43561673-07C9D5E6-4A8D-4946-865C-60DE8AD78F3DQ46086036-D5484946-AC2A-438D-8A16-BC820DB0B787Q46091265-10B0ABC0-7E46-400C-B154-2283DADF9840Q47284544-6773728D-1A61-49ED-84CD-213F1C04D917Q52991881-0289DA08-010C-45AC-82F6-170A7438D944Q53003551-8F1B2AC1-C022-48C8-AFF7-27EE416B9FA1Q58461238-358D3438-CB61-4128-BC60-16CCBA325EC5
P2860
Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Gleason scores of prostate bio ...... ence for systematic upgrading?
@ast
Gleason scores of prostate bio ...... ence for systematic upgrading?
@en
type
label
Gleason scores of prostate bio ...... ence for systematic upgrading?
@ast
Gleason scores of prostate bio ...... ence for systematic upgrading?
@en
prefLabel
Gleason scores of prostate bio ...... ence for systematic upgrading?
@ast
Gleason scores of prostate bio ...... ence for systematic upgrading?
@en
P2093
P2860
P356
P1433
P1476
Gleason scores of prostate bio ...... ence for systematic upgrading?
@en
P2093
Dan Theodorescu
Emily B Smith
Henry F Frierson
James C Boyd
Stacey E Mills
P2860
P304
P356
10.1002/CNCR.10457
P407
P577
2002-04-01T00:00:00Z